American Society of Haematology (ASH) Meeting

Phase 2 trial of bezuclastinib for SM partially completed

by Leonardo Jaimes, MD

The phase 2 Apex trial aiming to test bezuclastinib in patients with SM, has recently completed enrollment for part one of the trial.